ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $1.32B

      Shares

      2.69M

      % of Portfolio

      0.48%

      Average Buy Price

      $419

      Avg closing price
      Price range

      39 Ken Fisher Thermo Fisher Scientific Trades

      Ken Fisher's position in Thermo Fisher Scientific is currently worth $1.32B. That's 0.48% of their equity portfolio (62nd largest holding). The first Thermo Fisher Scientific trade was made in Q4 2015. Since then Ken Fisher bought shares 27 more times and sold shares on eleven occasions. The stake costed the investor $1.13B, netting the investor a gain of 17% so far.

      Avg closing price
      Price range
      Sold 0.9% shares (-25.6k shares) Q2 2025
      Avg closing price $417.51
      Price range $390.26 - $489.06
      Increased shares by 1.9% (+49.5k shares) Q1 2025
      Avg closing price $541.80
      Price range $497.60 - $606.57
      Increased shares by 1.1% (+29.3k shares) Q4 2024
      Avg closing price $548.87
      Price range $501.50 - $612.94
      Increased shares by 2.6% (+65.6k shares) Q3 2024
      Avg closing price $591.45
      Price range $531.86 - $624.21
      Increased shares by 2.9% (+73.6k shares) Q2 2024
      Avg closing price $572.88
      Price range $541.52 - $599.02
      Sold 2.9% shares (-74.3k shares) Q1 2024
      Avg closing price $561.14
      Price range $528.82 - $599.43
      Increased shares by 0.0% (+589 shares) Q4 2023
      Avg closing price $484.03
      Price range $431.41 - $532.94
      Increased shares by 4.7% (+114k shares) Q3 2023
      Avg closing price $532.87
      Price range $498.29 - $574.41
      Increased shares by 2.5% (+60.7k shares) Q2 2023
      Avg closing price $539.63
      Price range $508.46 - $591.13
      Increased shares by 1.9% (+44.9k shares) Q1 2023
      Avg closing price $563.62
      Price range $535.00 - $604.82
      Increased shares by 2.0% (+46k shares) Q4 2022
      Avg closing price $529.89
      Price range $484.71 - $571.38
      Sold 1.5% shares (-35.8k shares) Q3 2022
      Avg closing price $559.63
      Price range $507.19 - $604.49
      Increased shares by 3.7% (+83.9k shares) Q2 2022
      Avg closing price $550.42
      Price range $500.90 - $612.21
      Increased shares by 4.8% (+104k shares) Q1 2022
      Avg closing price $574.45
      Price range $524.00 - $644.92
      Increased shares by 7.0% (+140k shares) Q4 2021
      Avg closing price $624.35
      Price range $569.00 - $667.24
      Increased shares by 4.5% (+86.2k shares) Q3 2021
      Avg closing price $548.85
      Price range $509.53 - $609.78
      Increased shares by 6.2% (+112k shares) Q2 2021
      Avg closing price $471.83
      Price range $441.00 - $508.24
      Increased shares by 4.8% (+82.8k shares) Q1 2021
      Avg closing price $477.30
      Price range $439.85 - $518.83
      Increased shares by 7.2% (+116k shares) Q4 2020
      Avg closing price $468.87
      Price range $435.06 - $527.66
      Increased shares by 5.6% (+85.3k shares) Q3 2020
      Avg closing price $413.14
      Price range $359.77 - $441.52

      News about Thermo Fisher Scientific Inc. and Ken Fisher

      $7.1 Billion Medical Refrigerators Market and Industry Insights, 2024-2030, Featuring Strategic Analysis of 42 Major Players, Including Godrej, Haier Biomedical, Thermo Fisher Scientific

      $7.1 Billion Medical Refrigerators Market and Industry Insights, 2024-2030, Featuring Strategic Analysis of 42 Major Players, Including Godrej, Haier Biomedical, Thermo Fisher Scientific

      Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Medical Refrigerators - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's of...

      globenewswire.com globenewswire.com, about 1 year ago
      Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for

      Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for

      Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the...

      zacks.com zacks.com, about 1 year ago
      Here's How Thermo Fisher (TMO) is Placed Ahead of Q2 Earnings

      Here's How Thermo Fisher (TMO) is Placed Ahead of Q2 Earnings

      Strength in Analytical Instrument and Laboratory Products and Services segments is likely to have driven Thermo Fisher's (TMO) second-quarter 2024 performance.

      zacks.com zacks.com, about 1 year ago
      The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific

      The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific

      DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.

      zacks.com zacks.com, about 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×